Guzzo Giulia, Sciacovelli Marco, Bernardi Paolo, Rasola Andrea
CNR Neuroscience Institute and Department of Biomedical Sciences, University of Padova, 35121 Padova, Italy.
CNR Neuroscience Institute and Department of Biomedical Sciences, University of Padova, 35121 Padova, Italy. Medical Research Council Cancer Unit, University of Cambridge, Hutchison/MRC Research Centre, Cambridge, United Kingdom.
Oncotarget. 2014 Dec 15;5(23):11897-908. doi: 10.18632/oncotarget.2472.
TRAP1 is a mitochondrial chaperone highly expressed in many tumor types; it inhibits respiratory complex II, down-modulating its succinate dehydrogenase (SDH) enzymatic activity. SDH inhibition in turn leads to a pseudohypoxic state caused by succinate-dependent HIF1α stabilization and promotes neoplastic growth. Here we report that TRAP1 inhibition of SDH also shields cells from oxidative insults and from the ensuing lethal opening of the mitochondrial permeability transition pore. This anti-oxidant activity of TRAP1 protects tumor cells from death in conditions of nutrient paucity that mimic those encountered in the neoplasm during the process of malignant accrual, and it is required for in vitro tumorigenic growth. Our findings demonstrate that SDH inhibition by TRAP1 is oncogenic not only by inducing pseudohypoxia, but also by protecting tumor cells from oxidative stress.
TRAP1是一种在多种肿瘤类型中高表达的线粒体伴侣蛋白;它抑制呼吸复合物II,下调其琥珀酸脱氢酶(SDH)的酶活性。SDH抑制反过来会导致由琥珀酸依赖性HIF1α稳定化引起的假低氧状态,并促进肿瘤生长。在此我们报告,TRAP1对SDH的抑制作用还可保护细胞免受氧化损伤以及随后线粒体通透性转换孔的致命开放。TRAP1的这种抗氧化活性可保护肿瘤细胞在营养匮乏的条件下免于死亡,这种条件模拟了肿瘤在恶性增殖过程中所遇到的情况,并且是体外肿瘤发生性生长所必需的。我们的研究结果表明,TRAP1对SDH的抑制作用不仅通过诱导假低氧,还通过保护肿瘤细胞免受氧化应激而具有致癌性。